Oxaliplatin has been shown to increase inflammatory mediators including tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β)44, and immune cells such as dendritic cells and enhanced cytotoxic T cells elsewhere in lung carcinoma tissues of murine models45. This evidence concerns the gene IL1B and lung carcinoma.